Selvita S.A. is a leading biotechnology company that focuses on providing comprehensive drug discovery services. Established in Kraków, Poland, Selvita operates in the dynamic field of life sciences, primarily gearing its efforts toward accelerating the development of therapies through innovative research and development solutions. The company offers a wide range of services, including integrated projects, medicinal chemistry, and in vitro studies, catering mainly to the pharmaceutical and biotechnology industries. Selvita's work significantly contributes to the discovery of novel therapeutics and advancements in medical research. As a prominent contract research organization (CRO), it plays a critical role in bridging the gap between early scientific discoveries and the development of new drugs. This positioning within the biotechnology sector highlights its importance in fostering collaborative partnerships and research initiatives worldwide, ultimately enhancing the landscape of global medical advancements.